Hexa Reports Market Research Reports and Insightful Company Profiles Global Haematology Analyzers Market Size, Share, Strategies, Global Insights, Analysis and Forecasts 2016 Summary GlobalData's Medical Devices sector report, "Haematology Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Haematology Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Browse Detail Report With TOC@ http://www.hexareports.com/report/haematology-analyzersmedical-devices-pipeline-assessment-2016/details Scope - Extensive coverage of the Haematology Analyzers under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities Hexa Reports Market Research Reports and Insightful Company Profiles - The report reviews the major players involved in the development of Haematology Analyzers and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons To Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of Haematology Analyzers under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Request A Sample copy of This Report @ http://www.hexareports.com/sample/159328 Table Of Content 1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 8 2 Introduction 9 2.1 Haematology Analyzers Overview 9 3 Products under Development 10 3.1 Haematology Analyzers - Pipeline Products by Stage of Development 10 3.2 Haematology Analyzers - Pipeline Products by Territory 11 3.3 Haematology Analyzers - Pipeline Products by Regulatory Path 12 3.4 Haematology Analyzers - Pipeline Products by Estimated Approval Date 13 4 Haematology Analyzers - Pipeline Products under Development by Companies 14 4.1 Haematology Analyzers Companies - Pipeline Products by Stage of Development 14 4.2 Haematology Analyzers - Pipeline Products by Stage of Development 16 5 Haematology Analyzers Companies and Product Overview 17 5.1 Abbott Diagnostics Company Overview 17 5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Analyticon Biotechnologies AG Company Overview 18 5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 18 5.3 Apollo Medical Devices LLC Company Overview 21 5.3.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 21 Hexa Reports Market Research Reports and Insightful Company Profiles 5.4 Arkray, Inc. Company Overview 22 5.4.1 Arkray, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22 5.5 Auer Precision Company Overview 23 5.5.1 Auer Precision Pipeline Products & Ongoing Clinical Trials Overview 23 5.6 Axxin Company Overview 24 5.6.1 Axxin Pipeline Products & Ongoing Clinical Trials Overview 24 5.7 Baebies, Inc. Company Overview 25 5.7.1 Baebies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25 5.8 Columbia University Company Overview 26 5.8.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26 5.9 DiaSorin S.p.A Company Overview 27 5.9.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 27 5.10 Diatron Medical Instruments Limited Company Overview 29 5.10.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 29 5.11 Drew Scientific Co. Limited Company Overview 30 5.11.1 Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview 30 5.12 Ionu Biosystems Company Overview 32 5.12.1 Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview 32 5.13 IRIS International, Inc. Company Overview 33 5.13.1 IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33 5.14 Mindray Medical International Limited Company Overview 34 5.14.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 34 5.15 Noninvasix, Inc. Company Overview 37 5.15.1 Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37 5.16 Quotient Limited Company Overview 38 5.16.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 38 5.17 Roche Diagnostics International Ltd. Company Overview 40 5.17.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40 5.18 SigTuple Technologies Private Limited Company Overview 43 5.18.1 SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 43 5.19 SpinChip Diagnostics AS Company Overview 44 5.19.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 44 5.20 Sysmex Corporation Company Overview 45 5.20.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 45 5.21 T2 Biosystems, Inc. Company Overview 46 5.21.1 T2 Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46 5.22 Tarabios Company Overview 48 5.22.1 Tarabios Pipeline Products & Ongoing Clinical Trials Overview 48 5.23 The University of British Columbia Company Overview 49 5.23.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 49 5.24 University of Barcelona Company Overview 51 5.24.1 University of Barcelona Pipeline Products & Ongoing Clinical Trials Overview 51 Hexa Reports Market Research Reports and Insightful Company Profiles 5.25 Visca Corporation Company Overview 52 5.25.1 Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview 52 Browse Full Report @ http://www.hexareports.com/report/haematology-analyzers-medical-devicespipeline-assessment-2016/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in
GlobalData's Medical Devices sector report, "Haematology Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Haematology Analyzers currently in pipeline stage.
© Copyright 2024 Paperzz
